Brad Rovin

Employment

• The Ohio State University Wexner Medical Center

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (60)

• Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary
  Kidney International 2026 DOI: 10.1016/j.kint.2026.03.003
  +Save
• Tailoring KDIGO guidelines for lupus nephritis to the real world: a stratified and cost-aware approach
  Clinical Kidney Journal 2026 DOI: 10.1093/ckj/sfag267
  +Save
• Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome
  Science Translational Medicine 2026 DOI: 10.1126/scitranslmed.adw2206
  +Save
• Reply
  Arthritis & Rheumatology 2026 DOI: 10.1002/art.43343
  +Save
• Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
  Arthritis Care & Research 2026 DOI: 10.1002/acr.25616
  +Save
• Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
  Arthritis & Rheumatology 2026 DOI: 10.1002/art.43427
  +Save
• Role of lupus nephritis classification systems in everyday clinical practice: a questionnaire-based survey of the Renal Pathology Society (RPS)
  Clinical Kidney Journal 2026 DOI: 10.1093/ckj/sfag028
  +Save
• Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy
  Clinical Journal of the American Society of Nephrology 2026 DOI: 10.2215/CJN.0000000961
  +Save
• Clinical Remission as a Function of Exposure to Cyclophosphamide in Patients with Primary Membranous Nephropathy: A One-Year Cohort Study
  Glomerular Diseases 2026 DOI: 10.1159/000551814
  +Save
• Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study
  Arthritis Care & Research 2026 DOI: 10.1002/acr.80059
  +Save